1. Fukuda, Atsuo, Watanabe, Miho. 2018. Pathogenic potential of human SLC12A5 variants causing KCC2 dysfunction. In Brain research, 1710, 1-7. doi:10.1016/j.brainres.2018.12.025. https://pubmed.ncbi.nlm.nih.gov/30576625/
2. Gregory, Michael D, Kippenhan, J Shane, Callicott, Joseph H, Coppola, Richard, Berman, Karen F. . Sequence Variation Associated with SLC12A5 Gene Expression Is Linked to Brain Structure and Function in Healthy Adults. In Cerebral cortex (New York, N.Y. : 1991), 29, 4654-4661. doi:10.1093/cercor/bhy344. https://pubmed.ncbi.nlm.nih.gov/30668668/
3. Yuan, Shuai, He, Shao-Hua, Li, Lu-Yao, Hu, Hailiang, Zeng, Xian-Tao. 2023. A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1. In Cell death & disease, 14, 7. doi:10.1038/s41419-022-05544-8. https://pubmed.ncbi.nlm.nih.gov/36609444/
4. Yang, Gui-Ping, He, Wei-Peng, Tan, Jin-Feng, Xie, Dan, Yang, Guo-Fen. . Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma. In International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 29, 1280-1284. doi:10.1136/ijgc-2019-000229. https://pubmed.ncbi.nlm.nih.gov/31570543/
5. Järvelä, Viivi, Hamze, Mira, Komulainen-Ebrahim, Jonna, Medina, Igor, Immonen, Esa-Ville. 2024. A novel pathogenic SLC12A5 missense variant in epilepsy of infancy with migrating focal seizures causes impaired KCC2 chloride extrusion. In Frontiers in molecular neuroscience, 17, 1372662. doi:10.3389/fnmol.2024.1372662. https://pubmed.ncbi.nlm.nih.gov/38660387/
6. Jiang, Yi, Liao, Hong-Li, Chen, Li-Ya. 2021. A Pan-Cancer Analysis of SLC12A5 Reveals Its Correlations with Tumor Immunity. In Disease markers, 2021, 3062606. doi:10.1155/2021/3062606. https://pubmed.ncbi.nlm.nih.gov/34630736/
智鼠故事 
